HighTower Advisors »

Calidi Biotherap shares owned by HighTower Advisors

Quarter-by-quarter ownership of Calidi Biotherap (CLDI) shares owned by HighTower Advisors from 13F filings

Historical chart of HighTower Advisors investment in Calidi Biotherap

Tip: Access up to 7 years of quarterly data

All positions including Calidi Biotherap held by HighTower Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Calidi Biotherap by HighTower Advisors

Quarter filed Position value Share count Share price at filing
2025-06-30 $28k 120k 0.23
2025-03-31 $68k 120k 0.57
2024-12-31 $118k 102k 1.15

More positions owned by HighTower Advisors

Apple (AAPL)
Microsoft Corporation (MSFT)
Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
NVIDIA Corporation (NVDA)
Berkshire Hathaway Inc Del Cl A (BRK.A)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Exxon Mobil Corporation (XOM)
JPMorgan Chase & Co. (JPM)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Broadcom (AVGO)
Vanguard Index Fds Growth Etf (VUG)

View all positions for HighTower Advisors

Top funds holding Calidi Biotherap

Belpointe Asset Management
Advisor Group Holdings

View all funds holding Calidi Biotherap